.FDA refuses experimental MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Declines to Accept MDMA Therapy, Seeking Even More Research Study The New York TimesFDA Turns Down Ecstasy-Based Drug The Wall Street JournalFDA declines to accept novel MDMA treatment to treat post-traumatic stress disorder, along with request for more trial data CNNFDA declines initially experimental to deal with post-traumatic stress disorder, calling for additional research study The Washington Article.